Mechanisms for Lactobacillus rhamnosus treatment of intestinal infection by drug-resistant Escherichia coli

被引:2
|
作者
Li, Na [1 ]
Pang, Bing [1 ]
Li, Junjun [1 ]
Liu, Guanwen [1 ]
Xu, Xiaoguang [1 ]
Shao, Dongyan [1 ]
Jiang, Chunmei [1 ]
Yang, Baowei [2 ]
Shi, Junling [1 ]
机构
[1] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, 127 Youyi West Rd, Xian 710072, Shaanxi, Peoples R China
[2] Coll Food Sci & Engn, 28 Xinong Rd, Yangling 712100, Shaanxi, Peoples R China
基金
国家重点研发计划;
关键词
LACTIC-ACID BACTERIA; CELL-SURFACE; ADHESION; BARRIER; PROBIOTICS; INTEGRITY; STRAINS; MYOSIN; MUCUS; GG;
D O I
10.1039/d0fo00128g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of probiotics as therapeutic drugs is greatly important for the protection against threats of drug-resistant pathogen infection in both humans and animals. This study showed that Lactobacillus rhamnosus SHA113, previously isolated from breast milk of healthy humans, showed efficient therapeutic effects on infection by drug resistant Escherichia coli QBQ009. In addition to protecting the intestinal barrier via up-regulating the expression of tight junction proteins ZO-1 and occludin, it was also found that (1) both L. rhamnosus SHA113 and E. coli QBQ009 cells caused changes of the epithelial cell cytoskeleton and up-regulated the expression of phagocytosis-related proteins MYH2 in Caco-2 cells; however, only E. coli QBQ009 caused a strong decrease of cell viability. L. rhamnosus SHA113 treatment after E. coli QBQ009 infection significantly restored the damaged intestinal barrier and the changes of the epithelial cell cytoskeleton caused by E. coli QBQ009. (2) L. rhamnosus SHA113 showed a much higher adhesion rate to the intestinal tract and Caco-2 cells than E. coli QBQ009. The presence of E. coli QBQ009 significantly decreased the adhesion rate of L. rhamnosus SHA113, but not in reverse. (3) L. rhamnosus SHA113 had much higher self-coagulation than E. coli, and could strongly co-coagulate with E. coli QBQ009. The viability of E. coli QBQ009 greatly decreased after co-coagulation, while that of L. rhamnosus SHA113 was not influenced. (4) The polysaccharides produced by L. rhamnosus SHA113 significantly decreased the permeability of the intestinal tract and Caco2 cells, but had no remarkable influence on the adhesion rate of E. coli QBQ009. (5) Feeding L. rhamnosus SHA113 caused a significant reduction of Proteobacteria in the cecum of healthy mice, which was not significant in infected and treated mice. In summary, the decreased live pathogen amounts might be one of the decisive factors for the efficient cure of E. coli QBQ009 infection by L. rhamnosus SHA113, and the restoration of the intestinal barrier might be caused by the reduction of pathogens.
引用
收藏
页码:4428 / 4445
页数:18
相关论文
共 50 条
  • [21] Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense
    He, Xiaolong
    Zeng, Qing
    Puthiyakunnon, Santhosh
    Zeng, Zhijie
    Yang, Weijun
    Qiu, Jiawen
    Du, Lei
    Boddu, Swapna
    Wu, Tongwei
    Cai, Danxian
    Huang, Sheng-He
    Cao, Hong
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Lactobacillus rhamnosus GG supernatant enhance neonatal resistance to systemic Escherichia coli K1 infection by accelerating development of intestinal defense
    Xiaolong He
    Qing Zeng
    Santhosh Puthiyakunnon
    Zhijie Zeng
    Weijun Yang
    Jiawen Qiu
    Lei Du
    Swapna Boddu
    Tongwei Wu
    Danxian Cai
    Sheng-He Huang
    Hong Cao
    Scientific Reports, 7
  • [23] DRUG-RESISTANT AND R-FACTOR-BEARING ESCHERICHIA-COLI IN POULTRY
    KUMAR, A
    MISRA, DS
    SINGH, IP
    INDIAN JOURNAL OF ANIMAL SCIENCES, 1981, 51 (09): : 872 - 876
  • [24] COLORIMETRIC SERUM RESISTANCE ASSAY OF DRUG-RESISTANT ESCHERICHIA-COLI STRAINS
    YADAVA, JNS
    GOEL, R
    ANSARI, MQ
    CURRENT SCIENCE, 1982, 51 (21): : 1041 - 1042
  • [25] FREQUENCY OF DRUG-RESISTANT ESCHERICHIA-COLI IN THE INDIGENOUS FECAL FLORA IN RIYADH
    QADRI, SMH
    ALBALLAA, SR
    RABEA, N
    LEE, GC
    UENO, Y
    MEDICAL SCIENCE RESEARCH, 1993, 21 (17): : 651 - 652
  • [26] DRUG-RESISTANT ESCHERICHIA-COLI IN MEAT FROM CHICKENS FED ANTIBIOTICS
    GUNARATNE, KWB
    SPENCER, JV
    POULTRY SCIENCE, 1975, 54 (05) : 1769 - 1769
  • [27] Pandemic Bacteremic Escherichia Coli Strains: Evolution and Emergence of Drug-Resistant Pathogens
    Yair, Yael
    Gophna, Uri
    ESCHERICHIA COLI, A VERSATILE PATHOGEN, 2018, 416 : 163 - 180
  • [28] Rapid detection of drug-resistant Escherichia coli by Vitek 2 compact system
    Tshabuse, F.
    Buthelezi, N.
    Folami, A. M.
    Donnelly, L.
    Swalaha, F. M.
    WATER SA, 2022, 48 (04) : 450 - 456
  • [29] Synbiotic combination of Lactobacillus rhamnosus NCDC 298 and short chain fructooligosaccharides prevents enterotoxigenic Escherichia coli infection
    Anand, Santosh
    Mandal, Surajit
    Singh, Kumar Siddharth
    Patil, Prasad
    Tomar, Sudhir Kumar
    LWT-FOOD SCIENCE AND TECHNOLOGY, 2018, 98 : 329 - 334
  • [30] Tipranavir: A New Option for the Treatment of Drug-Resistant HIV Infection
    Temesgen, Zelalem
    Feinberg, Judith
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (06) : 761 - 769